[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 19, 1994

Direct Measurement of Lead in Bone A Promising Biomarker

Author Affiliations

From the Department of Community Medicine, Mount Sinai School of Medicine, New York, NY.

JAMA. 1994;271(3):239-240. doi:10.1001/jama.1994.03510270085045
Abstract

Chronic excessive exposure to lead is widespread in industrialized societies. In the United States, an estimated 3 million young children have a blood lead level of 0.50 μmol/L (10 μg/dL) or more, the level considered by the Centers for Disease Control and Prevention to indicate increased absorption.1 Also, more than 1.4 million industrial workers have the potential for chronic exposure through occupations such as stained glass manufacturing, battery making, and bridge demolishing.2

See also p 197.

Despite the extent of this exposure, great gaps exist in our knowledge of the chronic toxicity of lead.3 For example, we do not know the level of cumulative exposure in adults that is associated with chronic dysfunction of the central or peripheral nervous systems. We do not know whether chronic exposure is associated with motor neuron disease, parkinsonism, or other chronic neurological illnesses. We do not know the fraction of hypertension

First Page Preview View Large
First page PDF preview
First page PDF preview
×